Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CrH2O4 |
| Molecular Weight | 118.0096 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[Cr](O)(=O)=O
InChI
InChIKey=KRVSOGSZCMJSLX-UHFFFAOYSA-L
InChI=1S/Cr.2H2O.2O/h;2*1H2;;/q+2;;;;/p-2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of vitamin E on survival, glutathione reductase and formation of chromium (V) in Chinese hamster V-79 cells treated with sodium chromate (VI). | 1989 Apr |
|
| Investigations into the biochemical effects of region-specific nephrotoxins. | 1989 Feb |
|
| Assessment of urinary rat beta 2-microglobulin by enzyme immunoassay. | 1990 Aug |
|
| Effects of vitamins on chromium(VI)-induced damage. | 1991 May |
|
| Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. | 1991 May |
|
| Influence of o-phenanthroline on DNA single-strand breaks, alkali-labile sites, glutathione reductase, and formation of chromium(V) in Chinese hamster V-79 cells treated with sodium chromate (VI). | 1993 Sep |
|
| The role of iron chelators and oxygen in the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P450 oxidoreductase-dependent chromium(VI) reduction. | 1995 Mar |
|
| Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. | 2004 Jan |
|
| Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure. | 2005 Nov |
|
| Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. | 2008 Apr 18 |
|
| The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. | 2009 Mar 4 |
|
| Elucidation of the percutaneous absorption of chromium compounds by functional proteomics. | 2009 Nov |
|
| Inhibitory effect of Styrax Japonica Siebold et al. Zuccarini glycoprotein (38 kDa) on interleukin-1β and induction proteins in chromium(VI)-treated BNL CL.2 cells. | 2012 Aug |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SA8VOV0V7Q
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
236-881-5
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
ALTERNATIVE | |||
|
6769
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
7738-94-5
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
23234
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
33143
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
231-801-5
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
DTXSID8034455
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
24425
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
CHROMIC ACID
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
PRIMARY | |||
|
13530-68-2
Created by
admin on Sat Dec 16 09:08:59 GMT 2023 , Edited by admin on Sat Dec 16 09:08:59 GMT 2023
|
ALTERNATIVE |
SUBSTANCE RECORD
